Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Epstein-Barr Virus Infections

• Pembro Plus CAR T-cell Therapy in R/R in PMBCL
• L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH
• Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons
• Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Can
• Rituximab Monotherapy for EBV-HLH and CAEBV
• R-MVST Cells for Treatment of Viral Infections
• Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy
• Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Receive
• PD-1 Antibody for Reactive EBV After BMT
• Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection
• Inflammation and Co-Infections in D²EFT
• PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV
• EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
• Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
• Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
• ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
• Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma
• Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas
• A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
• Administration of Donor T Cells With the Caspase-9 Suicide Gene
• Modified Vaccinia Ankara (MVA) Vaccine Study
• Bortezomib Plus Rituximab for EBV+ PTLD
• Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection